NCT01522989 PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies Status UNKNOWN Phase PHASE1
NCT01522807 A Study Of Three PF-05190457 Formulations In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01521897 Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan) Status COMPLETED Phase N/A
NCT01521884 Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy Status COMPLETED Phase N/A
NCT01520870 Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. Status COMPLETED Phase PHASE2
NCT01519089 A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01517373 Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin Status COMPLETED Phase PHASE2
NCT01515722 Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder Status COMPLETED Phase NA
NCT01513928 A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects Status COMPLETED Phase PHASE1
NCT01513902 Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA) Status COMPLETED Phase PHASE1
NCT01512160 Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain Status TERMINATED Phase PHASE2
NCT01511497 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers Status COMPLETED Phase PHASE1
NCT01508845 A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption Status COMPLETED Phase NA
NCT01508117 Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients Status TERMINATED Phase PHASE2
NCT01500824 A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT01500551 Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis Status COMPLETED Phase PHASE2/PHASE3
NCT01499511 Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study Status COMPLETED Phase N/A
NCT01499290 Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections Status COMPLETED Phase PHASE3